Liabilities, Current in USD of Karbon-X Corp. from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Karbon-X Corp. quarterly Liabilities, Current history and change rate from Q2 2018 to Q3 2025.
  • Karbon-X Corp. Liabilities, Current for the quarter ending 31 Aug 2025 was $8.36M, a 5914% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

Karbon-X Corp. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8.36M +$8.22M +5914% 31 Aug 2025 10-Q 15 Oct 2025
Q2 2025 $7.69M +$6.85M +816% 31 May 2025 10-Q 15 Oct 2025
Q1 2025 $5.78M +$5.41M +1473% 28 Feb 2025 10-Q 18 Apr 2025
Q4 2024 $4.03M +$3.75M +1347% 30 Nov 2024 10-Q 21 Jan 2025
Q3 2024 $139K -$133K -48.9% 31 Aug 2024 10-Q 21 Oct 2024
Q2 2024 $840K +$645K +332% 31 May 2024 10-K/A 17 Sep 2025
Q1 2024 $367K 29 Feb 2024 10-Q 22 Apr 2024
Q4 2023 $279K 30 Nov 2023 10-Q/A 24 Jan 2024
Q3 2023 $272K 31 Aug 2023 10-Q 23 Oct 2023
Q2 2023 $194K +$161K +477% 31 May 2023 10-K 13 Sep 2024
Q2 2022 $33.7K -$51.9K -60.6% 31 May 2022 10-K 13 Sep 2023
Q4 2021 $98.3K +$47.5K +93.7% 30 Nov 2021 10-Q 12 Jan 2022
Q3 2021 $93.8K +$52K +124% 31 Aug 2021 10-Q 18 Oct 2021
Q2 2021 $85.6K +$50.5K +144% 31 May 2021 10-Q 12 Jan 2022
Q1 2021 $63K +$32K +103% 28 Feb 2021 10-Q 12 Apr 2021
Q4 2020 $50.8K +$24.6K +93.9% 30 Nov 2020 10-Q 14 Jan 2021
Q3 2020 $41.8K +$21.4K +105% 31 Aug 2020 10-Q 09 Oct 2020
Q2 2020 $35.1K +$22K +169% 31 May 2020 10-K 30 Aug 2021
Q1 2020 $31K +$22.1K +251% 29 Feb 2020 10-Q 14 Apr 2020
Q4 2019 $26.2K 30 Nov 2019 10-Q 15 Jan 2020
Q3 2019 $20.4K 31 Aug 2019 10-Q 10 Oct 2019
Q2 2019 $13.1K +$11.3K +659% 31 May 2019 10-K 31 Aug 2020
Q1 2019 $8.84K 28 Feb 2019 10-Q 05 Apr 2019
Q2 2018 $1.72K 31 May 2018 10-K 22 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.